Preferred Tranche A Warrants (to purchase Series A Convertible Voting Preferred
Issued 2025
Shares Underlying
Exercise Price
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 33 of Minerva Neurosciences, Inc.'s SEC filings and found 4 warrant series, 1 convertible, 1 ATM program, 2 shelf registrations and 3 completed offerings on file for NERV. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Nov 1, 2026.
Raise routes on file: active ATM + effective shelf · latest dilution event 126 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Jun 30, 2026 · ATM Sale
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2025
Shares Underlying
Exercise Price
Issued 2025
Shares Underlying
Exercise Price
Issued 2023
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Principal
Conversion Price
Issued 2026
Total capacity
Sold to date
Issued 2026
Total capacity
Remaining
Issued 2025
Total capacity
Remaining
Issued 2025
Gross proceeds
Price per share
Gross proceeds
Price per share
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z